lucentis

Generic: ranibizumab

Labeler: genentech, inc.
NDC Directory HUMAN PRESCRIPTION DRUG BLA Inactive Finished

Drug Facts

Product Profile

Brand Name lucentis
Generic Name ranibizumab
Labeler genentech, inc.
Dosage Form INJECTION, SOLUTION
Routes
INTRAVITREAL
Active Ingredients

ranibizumab 10 mg/mL

Manufacturer
Genentech, Inc.

Identifiers & Regulatory

Product NDC 50242-080
Product ID 50242-080_71a6df7b-906b-4de9-ad4f-200285958cdc
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category BLA
Application Number BLA125156
Listing Expiration 2026-12-31
Marketing Start 2006-06-30

Pharmacologic Class

Established (EPC)
vascular endothelial growth factor inhibitor [epc]
Mechanism of Action
vascular endothelial growth factor inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 50242080
Hyphenated Format 50242-080

Supplemental Identifiers

RxCUI
1864423 1864425 2045501 2045502
UNII
ZL1R02VT79
NUI
N0000193542 N0000193543

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name lucentis (source: ndc)
Generic Name ranibizumab (source: ndc)
Application Number BLA125156 (source: ndc)
Routes
INTRAVITREAL
source: ndc

Resolved Composition

Strengths
  • 10 mg/mL
source: ndc
Packaging
  • 1 SYRINGE, GLASS in 1 CARTON (50242-080-03) / .05 mL in 1 SYRINGE, GLASS
  • 1 SYRINGE, GLASS in 1 CARTON (50242-080-88) / .05 mL in 1 SYRINGE, GLASS
source: ndc

Packages (2)

Ingredients (1)

ranibizumab (10 mg/mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAVITREAL"], "spl_id": "71a6df7b-906b-4de9-ad4f-200285958cdc", "openfda": {"nui": ["N0000193542", "N0000193543"], "unii": ["ZL1R02VT79"], "rxcui": ["1864423", "1864425", "2045501", "2045502"], "spl_set_id": ["de4e66cc-ca05-4dc9-8262-e00e9b41c36d"], "pharm_class_epc": ["Vascular Endothelial Growth Factor Inhibitor [EPC]"], "pharm_class_moa": ["Vascular Endothelial Growth Factor Inhibitors [MoA]"], "manufacturer_name": ["Genentech, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 SYRINGE, GLASS in 1 CARTON (50242-080-03)  / .05 mL in 1 SYRINGE, GLASS", "package_ndc": "50242-080-03", "marketing_start_date": "20161013"}, {"sample": true, "description": "1 SYRINGE, GLASS in 1 CARTON (50242-080-88)  / .05 mL in 1 SYRINGE, GLASS", "package_ndc": "50242-080-88", "marketing_start_date": "20161013"}], "brand_name": "LUCENTIS", "product_id": "50242-080_71a6df7b-906b-4de9-ad4f-200285958cdc", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Vascular Endothelial Growth Factor Inhibitor [EPC]", "Vascular Endothelial Growth Factor Inhibitors [MoA]"], "product_ndc": "50242-080", "generic_name": "RANIBIZUMAB", "labeler_name": "Genentech, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "LUCENTIS", "active_ingredients": [{"name": "RANIBIZUMAB", "strength": "10 mg/mL"}], "application_number": "BLA125156", "marketing_category": "BLA", "marketing_start_date": "20060630", "listing_expiration_date": "20261231"}